Form D · Other

NEXTGEN PHARMA LLC

Toa Baja, PR · CIK 0001837314

Offering snapshot reported Dec 21, 2020 · SEC filing

Reported sold
$9M
Offering amount: $9M
Investors reported
36
Form D · investor count
Minimum accepted
$9M
Reported outside-investor minimum
First sale
Dec 6, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 21, 2020Initial$9,000,000No comparison36SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
Not reported

Source: Form D, filed Dec 21, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Federico Hernandez Director, Executive
Julian Londono Director, Executive
Kevin Mc Grath Director, Executive
Carmen Serrano Director, Executive
Robert Weakly Director, Executive
Steve Zellers Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
Pr 854 Km 4.3 Parque Industrial Sabana Seca
Toa Baja, PR, 00949